A carregar...
The Developing Role of Anti–Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer
The first studies of epidermal growth factor receptor (EGFR) inhibitors in metastatic colorectal cancer were begun before the predictive role of RAS mutations had been elucidated. Secondary analyses of many large randomized trials have shown that mutations in exons 2–4 of KRAS and NRAS, BRAF V600E m...
Na minha lista:
| Publicado no: | Oncology (Williston Park) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5752316/ https://ncbi.nlm.nih.gov/pubmed/29179247 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|